Strategic Investment Advisors MI Trims Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Strategic Investment Advisors MI decreased its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 0.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 29,343 shares of the real estate investment trust’s stock after selling 271 shares during the period. Strategic Investment Advisors MI’s holdings in Omega Healthcare Investors were worth $1,111,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. UMB Bank n.a. lifted its stake in shares of Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares during the period. Dunhill Financial LLC acquired a new position in Omega Healthcare Investors during the third quarter worth approximately $31,000. True Wealth Design LLC acquired a new position in Omega Healthcare Investors during the third quarter worth approximately $31,000. DiNuzzo Private Wealth Inc. acquired a new position in Omega Healthcare Investors during the third quarter worth approximately $33,000. Finally, Grove Bank & Trust acquired a new position in Omega Healthcare Investors during the fourth quarter worth approximately $30,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on OHI. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target for the company in a research report on Monday, December 9th. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target for the company. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research report on Thursday, October 31st. Finally, Mizuho increased their price objective on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research report on Thursday, December 5th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $41.10.

Omega Healthcare Investors Price Performance

OHI opened at $37.19 on Monday. The company has a fifty day simple moving average of $38.54 and a 200 day simple moving average of $38.94. The firm has a market cap of $10.04 billion, a price-to-earnings ratio of 27.34, a PEG ratio of 1.08 and a beta of 0.99. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.